|
HS Code |
637794 |
| Product Name | 5-Bromo-6-Chloronicotinic Acid |
| Cas Number | 90989-46-9 |
| Molecular Formula | C6H3BrClNO2 |
| Molecular Weight | 236.45 g/mol |
| Appearance | White to off-white solid |
| Purity | Typically ≥98% |
| Melting Point | 222-226°C |
| Solubility | Slightly soluble in water, soluble in DMSO and methanol |
| Storage Condition | Store at 2-8°C, tightly closed container |
| Synonyms | 5-bromo-6-chloropyridine-3-carboxylic acid |
| Smiles | C1=CC(=NC(=C1Cl)Br)C(=O)O |
| Inchi | InChI=1S/C6H3BrClNO2/c7-4-2-3(6(10)11)1-5(8)9-4/h1-2H,(H,10,11) |
As an accredited 5-Bromo-6-Chloronicotinic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Sealed amber glass bottle containing 25 grams of 5-Bromo-6-Chloronicotinic Acid, labeled with product details, hazard symbols, and batch number. |
| Shipping | 5-Bromo-6-Chloronicotinic Acid is shipped in tightly sealed, chemically resistant containers, protected from light, moisture, and incompatible substances. Packages comply with relevant safety and hazardous materials regulations. Proper labeling and documentation are included to ensure safe handling, transport, and prompt delivery, maintaining the product’s stability and integrity during shipping. |
| Storage | 5-Bromo-6-Chloronicotinic Acid should be stored in a tightly sealed container in a cool, dry, and well-ventilated area. It must be kept away from sources of ignition, moisture, and incompatible substances such as strong oxidizing agents. Protect from direct sunlight and store at room temperature or as recommended by the manufacturer. Ensure appropriate labeling and handle under conditions that minimize dust generation. |
Applications of 5-Bromo-6-Chloronicotinic Acid in Industrial ManufacturingAs a direct manufacturer, we supply 5-Bromo-6-Chloronicotinic Acid for strictly defined industrial domains with proven downstream applications. Below, we outline the principal segments where this specialty compound integrates into advanced synthesis workflows, supported by actual usage patterns and industry standards. 1. Pharmaceutical Intermediate for Active Pharmaceutical Ingredient (API) SynthesisOur material acts as a core pyridine derivative in the preparation of complex APIs, particularly for anti-infective, anti-inflammatory, and central nervous system therapies. Its halogen-substituted scaffold enables selective functionalization crucial for small-molecule drug discovery and generic synthesis, with process adoption anchored in route optimization and impurity control. Leading formulators choose this intermediate to streamline key steps in their API pipelines, responding to structure-activity trends and patent challenges. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Intermediate for Pyridinic Herbicide ManufacturingLeading crop science companies utilize this raw material as a ring-based starting unit for crafting selective herbicides targeting broadleaf weeds. The presence of both bromine and chlorine on the nicotinic acid ring enhances synthetic flexibility, forming basis for targeted halogen-exchange or condensation reactions central to the newest agrochemical actives. Its application supports stable production yield, essential for consistent downstream formulation batches in large-scale crop protection. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Specialty Chemical for OLED and Display Material SynthesisDevelopers and formulators in advanced materials industries draw on this heteroaromatic acid for synthesizing functionalized ligands and small-molecule emitters used in organic light-emitting diode (OLED) and thin-film transistor (TFT) display manufacturing. The electron-withdrawing halogens on the pyridine backbone enable coupling with electron donor groups, resulting in materials with well-defined photophysical and charge transport properties. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Intermediate for Veterinary Active IngredientsGlobal veterinary drug manufacturers employ this chemical for the synthesis of halogenated heterocyclic fragments found in anti-parasitic and anti-infective veterinary actives. The raw material allows reliable halogen patterns for targeted biological pathways in large-animal as well as companion-animal pharmaceutical products, supporting the manufacture of safe and effective veterinary intermediates in line with well-defined safety and purity protocols. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Precursor for Advanced Analytical Chemistry ReagentsProducers of analytical standards and high-purity reagents use this compound in the functionalization of reference standards and derivatization agents needed for residue analysis in food and environmental laboratories. The bromo-chloro-nicotinate structure provides a reactive site for high-specificity tagging or calibration compound synthesis, contributing to robust analytical methodology development and regulatory monitoring. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 5-Bromo-6-Chloronicotinic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every batch of 5-Bromo-6-Chloronicotinic Acid moves through our facility under careful observation and fine-tuned routines honed by years of hands-on production. We understand that chemists and researchers depend on the consistent quality of their raw materials, often at scales where even a minor change in purity or particle size can derail development or delay formulation work. The way this material behaves, dissolves, reacts, and contributes to final synthesis speaks less to testing certificates and much more to teamwork and attention at each stage of its journey. Our familiarity with its quirks sets our output apart.
Chemical manufacturing brings out the personalities of every compound, and 5-Bromo-6-Chloronicotinic Acid is no exception. From the first drums of precursors to the final stages of crystallization and drying, we sense subtle differences in color, smell, and texture that would not show up on routine QC sheets. Our technicians know by experience when the material has reached its ideal form—sharp, white to off-white crystals, neither sticky nor powdery, with a distinctive, slightly pungent note familiar to any who have processed halogenated pyridines. Every manufacturer leaves their imprint in the form of process tweaks, solvent selection, and handling preferences. This becomes evident to researchers down the line, often translating into smoother reactions and higher yields.
The production of 5-Bromo-6-Chloronicotinic Acid typically settles into a range of 98.5%–99.5% purity using industry-standard techniques, built around HPLC and NMR confirmation. Offerings outside these thresholds do not meet the expectations our partners have set for us. For practical reasons, the melting point should hover between 225–233°C.
Though the theoretical chemical formula C6H3BrClNO2 looks simple, the way a factory drives the process determines the physical characteristics seen in the final jar of product—density, bulkiness, and how freely the solid pours matter daily to our downstream partners. Purity numbers matter to an extent, but it is the absence of persistent halide, sulfate, or nitro impurities that makes a real difference. Even small traces of certain anions can influence subsequent couplings or substitutions, especially when 5-Bromo-6-Chloronicotinic Acid heads into pharmaceutical or agrochemical intermediates.
It takes discipline and routine background checks on solvents, careful water removal, and real-time observation to keep these impurities low. We do not just rely on a certificate; we follow every barrel of solvent, note every swing in the cooling curve, and track every filter cake’s appearance because experience has taught us how a good batch should behave through and through.
In our workshops, most 5-Bromo-6-Chloronicotinic Acid finds its way into pharmaceutical research, where its unique halogenation pattern enables modification not possible with common nicotinic acid derivatives. The bromo and chloro positions at 5 and 6 allow for selective cross-coupling—Suzuki, Buchwald, and related reactions all thrive on these moieties, offering access to functionalized pyridine scaffolds with high selectivity. The acid group remains a reliable anchor for covalent attachment or salt formation, trusted for its performance in solid-phase synthesis or as a handle in API construction.
We see many orders intended for contract research organizations focused on kinase inhibitors and crop-protection leads. The size of these batches may range from a kilogram for discovery routes up to metric tons as processes scale, and our production shifts readily accommodate this. We keep records of user feedback—it is not unusual to hear how minor shifts in our isolation process have improved their downstream work, be it through easier dissolution in organic solvents or less residual odor that carries through to later intermediates.
Unlike many generic halopyridines, 5-Bromo-6-Chloronicotinic Acid does not show the same broad reactivity as, say, 2-chloro-5-bromopyridine or unsubstituted pyridine-3-carboxylic acid. Our users count on the ortho-halogen arrangement for chemoselectivity, enabling functionalization that avoids unwanted byproducts. In practice, the chloro group is less reactive under many conditions than the bromo group—a trait synthetic chemists exploit when planning stepwise substitution. The presence of both a carboxylic acid and dual halides opens up routes impossible with singly halogenated or other pyridine acids.
We know this not from catalog copy, but by having supported dozens of scale-up programs where subtle tweaks—stirring speed in the borylation, sequence of addition—matter more than what a printed specification reveals. Too often, minor impurities or unexpected solvation will confound a pilot-scale run. Since we are the originator, not a reseller, if there is an issue on the bench, we trace it back to the reactor and resolve it—not pass blame up or down the supply chain.
Competing manufacturers often focus on throughput at the expense of trace contaminants, solvent residues, or handling stability. For 5-Bromo-6-Chloronicotinic Acid, even low levels of certain byproducts—multi-halogenated or oxidized impurities—create headaches for end users. Through years in the trenches of halogenated heterocycle chemistry, we recognize that the actual needs extend beyond a product datasheet. A robust acid wash, repeated crystallization, and slow drying reduce solvent carryover and mechanical fines, which later affect everything from filtration rates to color in complex reactions.
Every batch produced in our facility passes through multiple critical eyes—often chemists who have worked both upstream and downstream. Having handled both large-volume export batches and custom pharma lots, we notice that expectations differ. Large agrochemical makers appreciate predictable bulk density for smooth handling by their automated feeders, while pharma partners watch for both highest purity and lowest trace contaminants, especially if the intermediate steps are not purified extensively.
We answer these needs with careful attention to each parameter visible during manufacturing. If particle size shifts outside agreed boundaries, or if we see color or odor drifting, we intervene directly. Sometimes that means adjusting a drying protocol to prevent caking, other times running an additional charcoal polish to catch persistent chromophores. The difference adds up—it may not stand out in a wearisome certificate of analysis, but work at scale proves its value.
Global shipments uncork new challenges—heat and moisture can transform some halopyridines if packaging is insufficient. We have learned to control humidity tightly and layer barrier packaging, having seen the headaches faint yellowing can cause for an otherwise perfectly pure batch. Users appreciate packaging that is easy to open and reseal, limiting exposure to ambient air and preserving product for longer research cycles. Experience with both local and export customers ensures we do not cut corners on drums, bags, or liners.
Most customers who come to us have already tried other halopyridine acids. The usual suspects—2-bromo-5-chloronicotinic acid, 3-bromo-6-chloronicotinic acid, mono-halogenated analogs—show different patterns of substitution, affecting both how they react and which final molecules are available. The 5-bromo-6-chloro pattern enables unique cross-coupling and aminolysis selectivity, allowing for complex, multi-step drug candidates that could not be assembled without this framework.
Mono-halogenated acids often fail in providing enough functional elbow room, especially where orthogonal substitutions are key. Double-halogenated acids with substitution on non-adjacent carbons open up different chemistry, often complicating downstream control. The unique arrangement in 5-Bromo-6-Chloronicotinic Acid lets project chemists install two distinct groups in close proximity—something not possible with more commonly available products.
From an industrial standpoint, each variant demands adjusted raw material supply, solvent handling, and waste control practices. 5-Bromo-6-Chloronicotinic Acid’s production leaves specific burdens at the environmental and operational level—halide wastes, unique exhaust controls for low level chlorinated emissions, and coordination with waste processors—challenges that must be seen to, not just referenced on a best-practices checklist. Our ownership of the process reflects a firm commitment to these real-world tradeoffs.
No manufacturing route escapes occasional issues. We’ve had runs where purification did not proceed as usual—solvent ratios slightly off, equipment running at the edge of tolerance, a new impurity showing up unexpectedly. Chemists on the production line have to adapt on their feet, applying knowledge built from years of similar casework. Cross-contamination from shared equipment sometimes makes its mark; besides equipment cleaning, close monitoring of each batch’s fingerprint is necessary.
Transparency with our partners leads to real corrections—not a game of finger-pointing but a conversation about how the real compound interacts in their hands. We often work out solutions together, sometimes customizing the isolation steps or refining the specification as new needs arise. Special requests for particle size distribution, low alkali content, or custom solvents for crystallization can be handled directly. Only a manufacturer who controls every step can offer this flexibility.
We have taken on customers seeking to solve pilot-plant headaches rooted in source material variation. They have tried a string of traders and resellers, and their processes drift batch to batch with no real corrective recourse. By dealing directly with production chemists and QC specialists who have seen these material behaviors up close, users report better reproducibility, higher yields, fewer ghost peaks, and far fewer failed scale-ups. Years of open feedback loops and detailed technical discussions shape our batches, helping to align physical properties like porosity and handling strength to what actually works in the lab or plant—not just what looks right on a paper.
The market for advanced pyridine intermediates grows with the shifting landscape of pharmaceutical, agricultural, and chemical research. 5-Bromo-6-Chloronicotinic Acid stands as a testament to how targeted process improvements translate into practical advantage. By owning the full production chain, we keep open lines with researchers, regularly reviewing both standard and custom requests.
We continuously review and seek incremental improvements—sometimes adjusting intermediate washing sequences, sometimes reworking agitation or filtration setups. Feedback from each user is passed directly to our technical team, looping into the next set of process changes. Adjusting the steps or timing can change yield and impurity profile in ways that directly affect user satisfaction. The tight control of temperature, agitation speed, vacuum levels, and pH tracking pays off not only in certificates but in real usability.
Chemical R&D cycles have grown shorter and more demanding. Testing new targets at rapid pace creates pressure on supply, scale-up, and traceability. Downstream players value a supply partner who knows their material exactly—who understands that repeatability and direct support beat cost savings at the sourcing level. Quality concerns gain urgency as a single faulty batch makes a difference not only financially, but also in lost research time and regulatory hassle.
We believe that chemical manufacturing built on real experience adds durability to research supply—direct troubleshooting, openness about process limitations, and collaborative technical relationships matter more over the long term than price or theoretical specifications. Our technical teams regularly discuss synthetic details and comparative routes, encouraging feedback and adjusting processes accordingly. This approach does not just secure repeat orders; it raises the standard across the sector by demonstrating what is possible when end-users are seen as partners rather than transactions.
Sustainable practice and knowledge-sharing remain at the core of our methods. Responsible management of halogenated wastes, continuous assessment of water and energy use, and compliance with up-to-date regulatory frameworks secure both community health and the trust of our workforce. What happens inside the plant ought to support not only global customers but also the staff and community who make each project possible. As regulations on hazardous intermediates tighten, our capacity to preemptively address these standards sets us apart and makes long-term cooperation easier for end users seeking compliance with new laws.
Whether supporting discovery chemists working on milligrams or process development teams scaling into metric tons, we believe reliable 5-Bromo-6-Chloronicotinic Acid must come from a factory whose operators have a deep, day-to-day knowledge of how each process decision affects the ultimate end-user. We do not isolate responsibility or keep technical support in distant offices—chemists who run the line can speak to chemists working in a research lab, updating both internal and customer-facing protocols as new data appears.
Ongoing investment in automation and better process controls shortens the time from order to delivery, tightening reproducibility and minimizing human error while keeping the benefits of experienced oversight. As we update methodologies, we document every change and project its impact on real-world performance, not just nominal yields or cost savings. We share these results with our customers and seek their input, closing a feedback loop that grows sharper with every production cycle.
Every kilogram of 5-Bromo-6-Chloronicotinic Acid issued from our reactors reflects both advanced process technology and lessons gained through practical troubleshooting. There are always areas for improvement, but listening closely to users and regularly training our operators gives each batch a reliability and consistency not available from e-marketplace traders or label-wrapped intermediaries from faceless sources.
Chemistry is an evolving field, and those who make core intermediates have a responsibility to keep pace. Our daily work with 5-Bromo-6-Chloronicotinic Acid is marked by that respect—for the demands of laboratory users, for the tight schedules faced by process teams, and for the plant workforce who keeps standards high in the face of routine and exception alike. By combining open communication, rigorous process control, and readiness to adapt, we offer not just a chemical, but a partnership anchored in technical skill and human understanding.